JPWO2023276861A1 - - Google Patents

Info

Publication number
JPWO2023276861A1
JPWO2023276861A1 JP2023531886A JP2023531886A JPWO2023276861A1 JP WO2023276861 A1 JPWO2023276861 A1 JP WO2023276861A1 JP 2023531886 A JP2023531886 A JP 2023531886A JP 2023531886 A JP2023531886 A JP 2023531886A JP WO2023276861 A1 JPWO2023276861 A1 JP WO2023276861A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023531886A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023276861A1 publication Critical patent/JPWO2023276861A1/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023531886A 2021-06-28 2022-06-24 Pending JPWO2023276861A1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021106397 2021-06-28
PCT/JP2022/025218 WO2023276861A1 (ja) 2021-06-28 2022-06-24 精子所見を改善するための経口摂取用組成物

Publications (1)

Publication Number Publication Date
JPWO2023276861A1 true JPWO2023276861A1 (pt) 2023-01-05

Family

ID=84691275

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023531886A Pending JPWO2023276861A1 (pt) 2021-06-28 2022-06-24

Country Status (3)

Country Link
JP (1) JPWO2023276861A1 (pt)
CN (1) CN118201499A (pt)
WO (1) WO2023276861A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1051914A1 (de) * 1999-05-08 2000-11-15 DSM Fine Chemicals Austria GmbH Verwendung von Kreatin als Futterzusatz
US20060154993A1 (en) * 2004-12-17 2006-07-13 Littarru Gian P Method for treating and preventing male infertility
CA2683858A1 (en) * 2007-04-12 2008-10-23 Oxis International, Inc. Ergothioneine and/or its derivatives as a cell preservative
ES2815659T3 (es) * 2014-08-18 2021-03-30 Pan Montojo Francisco El ácido glicólico mejora la motilidad del esperma
JPWO2021132655A1 (pt) * 2019-12-27 2021-07-01

Also Published As

Publication number Publication date
WO2023276861A1 (ja) 2023-01-05
CN118201499A (zh) 2024-06-14

Similar Documents

Publication Publication Date Title
BR112023005462A2 (pt)
BR112023012656A2 (pt)
BR112021014123A2 (pt)
BR112022009896A2 (pt)
BR112023009656A2 (pt)
BR112022024743A2 (pt)
BR112023006729A2 (pt)
BR102021018859A2 (pt)
BR102021015500A2 (pt)
BR112023008622A2 (pt)
BR112023011738A2 (pt)
JPWO2023276861A1 (pt)
BR112023016292A2 (pt)
BR112023004146A2 (pt)
BR112023011539A2 (pt)
BR112023011610A2 (pt)
BR112023008976A2 (pt)
BR102021020147A2 (pt)
BR102021018926A2 (pt)
BR102021018167A2 (pt)
BR102021017576A2 (pt)
BR102021016837A2 (pt)
BR102021016375A2 (pt)
BR102021016176A2 (pt)
BR102021016200A2 (pt)